" /> Crenolanib - CISMeF





Preferred Label : Crenolanib;

NCIt synonyms : PDGFR Inhibitor CP-868596; 4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1Hbenzimidazol-1-yl]-8-quinolinyl]-; [1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine; CP-868 596;

NCIt definition : An orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types.;

UNII : LQF7I567TQ;

InChIKey : DYNHJHQFHQTFTP-UHFFFAOYSA-N;

CAS number : 670220-88-9;

Molecule name : CP-868,596; CP-868596; CP 868 596;

Chemical formula : C26H29N5O2;

Codes from synonyms : 117;

Details


You can consult :


Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.